Found 7 matching trials
Expanded Access to Elezanumab N/A This is an expanded access program (EAP) for eligible participants. This pr...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI) PHASE2 Acute Spinal Cord Injury (SCI) is a rare injury that leads to permanent neu...
Show More Location
University of California Davis Health /ID# 224892
Learn More & Join Trial
[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis PHASE1 This open-label positron emission tomography (PET) study is designed to det...
Show More Location
Site Reference ID/Investigator# 141463
Learn More & Join Trial
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis PHASE2 The purpose of this study is to evaluate the safety and efficacy of elezanu...
Show More Location
University of Alabama at Birmingham - Main /ID# 204618
Learn More & Join Trial
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis PHASE2 The purpose of this study is to evaluate the safety and efficacy of elezanu...
Show More Location
St. Josephs Hospital and Med Center /ID# 202809
Learn More & Join Trial
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis PHASE1 This study seeks to evaluate the safety, tolerability, pharmacokinetics (PK...
Show More Location
Compass Research LLC
Learn More & Join Trial
A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke PHASE2 Stroke is one of the leading causes death and major functional disability w...
Show More Location
Mayo Clinic Arizona /ID# 214957
Learn More & Join Trial